HNSBF - Hansa Biopharma to host conference call to provide interim results for first half 2021 and Business Update

PR Newswire

LUND, Sweden , July 1, 2021 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January- June 2021 at 8:00 CET on July 15, 2021 . All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET / 8:00am EST . The event will be hosted by Hansa Biopharma's CEO, Søren Tulstrup, and CFO, Donato Spota , and the presentation will be held in English.

Slides used in the presentation will be live on the company website during the call under "Events & Webcast," and will also be made available online after the call. Link to presentation

To participate in the telephone conference, please use the dial-in details provided below:

Sweden : +46 850 558 368

United Kingdom : +44 333 300 92 72

United States : +1 646 722 49 57

The webcast will be available on https://streams.eventcdn.net/hansa/interim-report-for-january-june-2021/

Updated Calendar and Events 2021

July 15, 2021 Interim report for Jan- Jun 2021

July 15 , 2021       William Blair Biotech Focus Conference, 2021 (virtual)

Aug 25 , 2021       Handelsbanken Life Science Innovation Seminar, Stockholm

Aug 31 , 2021       Presentation at Penser Access, Skåne

Sep 2 , 2021         Pareto Healthcare Conference, Stockholm (virtual)

Sep 13-15 , 2021  MorganStanley Global Healthcare Conference (virtual)

Sep 14 , 2021       HC Wainwright Annual Global Investment Conference (virtual)

Sep 17 , 2021       Danske Bank Life Science event "Platform companies" (virtual)

Oct 21, 2021 Interim report for Jan- Sep 2021

Nov 25 , 2021       Erik Penser Banks Bolagsdag, Stockholm or virtual

CONTACT:

For further information, please contact:

Klaus Sindahl , Head of Investor Relations

Hansa Biopharma

Mobile: +46 (0) 709-298 269

E-mail: klaus.sindahl@hansabiopharma.com

Katja Margell

Head of Corporate Communications

Hansa Biopharma

Mobile: +46 (0) 768-198 326

E-mail: katja.margell@hansabiopharma.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-host-conference-call-to-provide-interim-results-for-first-half-2021-and-business-,c3374552

The following files are available for download:

SOURCE Hansa Biopharma AB